Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

NCT06307093 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Melanoma
Squamous Non-small-cell Lung Cancer
Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: RPH-075
DRUG: Keytruda®

Sponsor

R-Pharm

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]